companiesCompany
NextSource Biotechnology
aka NextSource Biotechnology, LLC, NextSource Pharma
NextSource Biotechnology is the Florida specialty pharma that sells lomustine in the United States as Gleostine, the nitrosourea chemotherapy used in brain tumours and Hodgkin lymphoma.
Overview
NextSource Biotechnology is a Miami-based specialty pharmaceutical company. It acquired US rights to lomustine (formerly CeeNU) and markets it as Gleostine, a capsule alkylating agent approved for brain tumours after surgery and radiotherapy and for Hodgkin lymphoma after other treatments. The company drew attention for steep price increases on the drug after the acquisition.
Headquarters
Miami, Florida, US
Scorecard
All companies#158of 1181 companies, score 31
- approved products +6
- modalities +2
- regions +2
- registry trials +21
1 approved, 0 in phase 3, 0 earlier, 0 targets, 106 registry studies. Formula on the scorecards page.
Type
pharma